1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Oncology - EUROPEAN PANORAMA

Oncology - EUROPEAN PANORAMA

  • May 2015
  • -
  • Expernova
  • -
  • 434 pages

The following Panorama contains a detailed overview of the Scientific Expertise on Oncology, in Europe.



Cancer is a pathology characterized by uncontrolled and cellular proliferation which causes the death of millions of people worldwide every year. Lifestyles, aging, population growth and rising treatment costs, are new challenges for the fight against cancer. Lifestyle (diet and smoking), exposure to carcinogens, and hereditary factors are the main causes of cancer, amongst which the most commonly diagnosed are lung, breast, and colorectal cancer.
With almost 22 million new annual cases expected in 2030, it is essential that the domain of oncology evolves and develops. The needs of patients in oncology change requiring this special branch of medical study, diagnostic and therapeutic management to reflect on new diagnostic and therapeutic approaches. Thanks to promising, innovative treatments and new therapies, we are already observing undeniable advances which have a real impact on the chances of survival.
The experts in oncology are looking toward a future focused on personalized medicine, out-patient care and successful methods of cured patients. The development of techniques for mini or non-invasive procedures and high-definition scanners dedicated to patients, are also major topics for future development.



Featuring 20 companies’ profiles such as Novartis International and Sanofi Aventis, and 25 R&D Laboratories such as the Department of Pharmaceutical Sciences of Utrecht University, or the Institut Gustave Roussy of the Université Paris-Sud, this report is ideal for anyone wanting:



- Identify R&D Partners,



- Obtain IP & Technologic Intelligence,



- Develop your R&D Partnerships,



- And also benchmark competitors.



…all on a global scale.



You will also find 40 expert’s profiles, containing their scientific works and details of their field of expertise.



These Key Innovation Leaders are based in Europe (France, Germany…).





For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why companies such as Novartis International are leaders on Oncology.





A Panorama is composed of:

- A global overview of the subject (issues, distribution of sources of expertise, international networks, European projects, main standards...)

- A selection of scientific profiles of actors (research centers , companies, experts)

- A selection of targeted works (from 50 different types of scientific and technical documents from more than 250 data sources).



Here are some examples of our data sources:



Research institutes databases (NASA, MIT, Fraunhofer, ...)



Patent Databases (European Patent Office, USPTO, ...)



Thematic Databases (MedLine/PubMed, INRA, ...)



Project Databases (Cordis FP-7, FP-6, ...)



Panorama are generated and updated with the unique mapping technology developed by Expernova, which covers 52 countries. Expernova data base is constantly growing, so each Panorama updated at any given time is potentially different from the others Panorama generated at other times on the same subject.





SCOPE OF THE PANORAMA

medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent, oncological disease, oncology nursing, gynecologic oncology




Table Of Contents

Oncology - EUROPEAN PANORAMA
I. General Panorama


1. Innovation Opportunities

2. Global ecosystem : overview

3. Focus : Funded european projects

4. Focus : calls for proposal

5. Focus : ISO / CEN Standards




II. Selection of key-profiles and innovation leaders


1. 30 RandD Labs profiles

2. 30 Companies Profiles

3. 50 Experts profiles




III. Targeted documents


1. 25 Scientific works

2. 25 Patent families




APPENDIX

- Labs Index

- Companies Index

- Experts Index

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Surgical/Operating Microscopes Market by Application, End User - Global Forecast to 2021

Surgical/Operating Microscopes Market by Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global surgical/operating microscopes market is expected to reach USD 915.6 million in 2021 from USD 508.1 million in 2016, at a CAGR of 12.5% from 2016 to 2021. The increasing use of fluorescence ...

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017

Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017

  • $ 2995
  • Industry report
  • February 2017
  • by Currentpartnering

Summary The Global Personalized Medicine in Oncology Partnering Terms and Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.